Anti-RUNX3 antibody [R3-5G4]
- BOND RX™ Validated
- KO Validated
- What is this?
1
(2 Reviews)
|
(34 Publications)
Mouse Monoclonal RUNX3 antibody. Suitable for IHC-P, Flow Cyt (Intra), WB and reacts with Human samples. Cited in 34 publications.
View Alternative Names
AML2, CBFA3, PEBP2A3, RUNX3, Runt-related transcription factor 3, Acute myeloid leukemia 2 protein, Core-binding factor subunit alpha-3, Oncogene AML-2, Polyomavirus enhancer-binding protein 2 alpha C subunit, SL3-3 enhancer factor 1 alpha C subunit, SL3/AKV core-binding factor alpha C subunit, CBF-alpha-3, PEA2-alpha C, PEBP2-alpha C
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RUNX3 antibody [R3-5G4] (AB40278)
IHC image of RUNX3 staining in human lymphoma FFPE section, performed on a BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab40278, 1µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-RUNX3 antibody [R3-5G4] (AB40278)
Overlay histogram showing HEK293 cells stained with ab40278 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab40278, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
- WB
Project
Western blot - Anti-RUNX3 antibody [R3-5G4] (AB40278)
All lanes:
Western blot - Anti-RUNX3 antibody [R3-5G4] (ab40278) at 1 µg/mL
Lane 1:
Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate at 10 µg
Lane 2:
Raji (Human Burkitt's lymphoma cell line) Whole Cell Lysate at 10 µg
Lane 3:
Western blot - SW480 whole cell lysate (<a href='/en-us/products/cell-lysates/sw480-whole-cell-lysate-ab3957'>ab3957</a>) at 10 µg
Secondary
All lanes:
IRDye 680 Conjugated Rabbit Anti-Mouse IgG (H+L) at 1/10000 dilution
Predicted band size: 44 kDa
Observed band size: 46 kDa
false
- WB
Supplier Data
Western blot - Anti-RUNX3 antibody [R3-5G4] (AB40278)
Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : RUNX3 knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HeLa whole cell lysate (20 μg)
Lanes 1 - 3 : Merged signal (red and green). Green - ab40278 observed at 44 kDa. Red - loading control, ab176560, observed at 50 kDa.
ab40278 was shown to specifically react with RUNX3 in wild-type HAP1 cells as signal was lost in RUNX3 knockout cells. Wild-type and RUNX3 knockout samples were subjected to SDS-PAGE. ab40278 and ab176560 (Rabbit anti-alpha Tubulin loading control) were incubated overnight at 4°C at 1 μg/ml and 1/20000 dilution respectively. Blots were developed with Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed ab216772 and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed ab216777 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-RUNX3 antibody [R3-5G4] (ab40278)
Predicted band size: 44 kDa
false
Related conjugates and formulations (1)
-
Anti-RUNX3 antibody [R3-5G4] - BSA and Azide free
Reactivity data
Product details
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The function of RUNX3 involves the regulation of cell proliferation differentiation and apoptosis. RUNX3 often forms a complex with the core-binding factor beta (CBFβ) enhancing its stability and DNA-binding capability. This protein is essential in maintaining cellular homeostasis and influencing the immune response particularly through its role in T cell development.
Pathways
RUNX3 is heavily involved in the TGF-beta signaling pathway and the Wnt signaling pathway. It interacts with several proteins such as SMADs in the TGF-beta pathway to modulate gene expression that affects cell growth and survival. Interaction with beta-catenin in the Wnt signaling pathway further emphasizes its importance in regulating cell fate decisions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (34)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in immunology 15:1430136 PubMed39822248
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cells 12: PubMed37887282
2023
Applications
Unspecified application
Species
Unspecified reactive species
BMC cancer 23:652 PubMed37438719
2023
Applications
Unspecified application
Species
Unspecified reactive species
Chinese medical journal 135:2089-2097 PubMed35143426
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular gastroenterology and hepatology 13:1317-1345 PubMed35074568
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death and differentiation 28:1251-1269 PubMed33116296
2020
Applications
Unspecified application
Species
Unspecified reactive species
Clinical cancer research : an official journal of the American Association for Cancer Research 26:6600-6609 PubMed32998960
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cancer letters 491:22-35 PubMed32730779
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 24:6308-6323 PubMed32307917
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 43:1289-1299 PubMed32323849
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com